IMMUNOVATIVE, INC. (IMUN)

Good evening to you all,

Many of us like to wait for lunch time to buy shares.
Here is one penny stock I found to share with you, currently trading at $0.29, with a volume over the average.

This penny stock is IMUN as you can see from the title.

Immunovative, Inc. has been granted an exclusive, worldwide license to commercialize any products covered under Immunovative Therapies, Ltd.’s current issued and pending patent application portfolio, as well as the rights to any future patent applications, including improvements or modifications to the existing applications and any corresponding improvements or new versions of the existing products.

Immunovative Therapies, Ltd. (“ITL”) is an Israeli biopharmaceutical company that was founded in May 2004 with financial support from the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world-renowned Israel technological incubator program. ITL was the Misgav Venture Accelerator’s candidate for the prize for the outstanding incubator project of 2006, awarded by the Office of the Chief Scientist. ITL specializes in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for treatment of cancer and infectious disease. ITL is developing a new class of immunotherapy drugs designed to harness the power of the immune system to treat cancer. ITL has two experimental immunotherapy products for the treatment of cancer in clinical development: AlloStim™ and AlloVax™ covered by Immunovative’s 10 U.S. patents granted, 15 U.S. patents pending and 26 corresponding applications pending internationally.

Upon successful completion of certain clinical trials and payment in full by Immunovative, Inc. of $10 million, Immunovative, Inc. and ITL intend to consummate a transaction in which Immunovative, Inc. and ITL will merge to become a single entity. ITL’s shareholders will own 75% of the new entity shares and the Immunovative, Inc.’s shareholders will own 25% of the new entity shares on a fully diluted basis, subject to adjustment. (imun.com)

IMUN has released news this morning which should be able to see this penny stock go up this week.

you can read the news at http://barchart.com/headlines/story.php?id=5773894

I have a good feeling this stock can make us happy this week, but don't rely on my opinion.

Do your own research prior to buying any stock, especially pennies.

Good luck to you all!